SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-000901
Filing Date
2020-01-09
Accepted
2020-01-09 18:53:37
Documents
1
Period of Report
2019-12-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5778
  Complete submission text file 0000899243-20-000901.txt   7160
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Fox Jonathan C (Reporting) CIK: 0001655016 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38533 | Film No.: 20519169

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences